{"cik":"0002020932","ticker":"AGMB","name":"Agomab Therapeutics NV","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"C9","fiscal_year_end":"1231","first_filing_date":"2026-05-15","last_filing_date":"2026-09-11","url":"/sec/cik-0002020932","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001104659-26-115567","form_type":"6-K","form_type_family":"current","doc_date":"2026-10-13","title":"6-K — AgomAb Therapeutics NV — 2026-10-13","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-115567","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-115567-index.html"},{"accession_number":"0002120886-26-000001","form_type":"4","form_type_family":"insider","doc_date":"2026-10-07","title":"4 — AgomAb Therapeutics NV — 2026-10-07","url_slug":"/sec/cik-0002020932/4/0002120886-26-000001","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0002120886-26-000001-index.html"},{"accession_number":"0002119332-26-000001","form_type":"4","form_type_family":"insider","doc_date":"2026-10-07","title":"4 — AgomAb Therapeutics NV — 2026-10-07","url_slug":"/sec/cik-0002020932/4/0002119332-26-000001","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0002119332-26-000001-index.html"},{"accession_number":"0001104659-26-112564","form_type":"6-K","form_type_family":"current","doc_date":"2026-10-01","title":"6-K — AgomAb Therapeutics NV — 2026-10-01","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-112564","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-112564-index.html"},{"accession_number":"0001104659-26-107915","form_type":"4","form_type_family":"insider","doc_date":"2026-09-15","title":"4 — AgomAb Therapeutics NV — 2026-09-15","url_slug":"/sec/cik-0002020932/4/0001104659-26-107915","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-107915-index.html"},{"accession_number":"0001104659-26-107912","form_type":"3","form_type_family":"insider","doc_date":"2026-09-15","title":"3 — AgomAb Therapeutics NV — 2026-09-15","url_slug":"/sec/cik-0002020932/3/0001104659-26-107912","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-107912-index.html"},{"accession_number":"0001104659-26-107500","form_type":"6-K","form_type_family":"current","doc_date":"2026-09-14","title":"6-K — Agomab Therapeutics NV — 2026-09-14","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-107500","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-107500-index.html"},{"accession_number":"0001104659-26-107117","form_type":"6-K","form_type_family":"current","doc_date":"2026-09-11","title":"6-K — Agomab Therapeutics NV — 2026-09-11","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-107117","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-107117-index.html"},{"accession_number":"0001104659-26-093390","form_type":"6-K","form_type_family":"current","doc_date":"2026-08-10","title":"6-K — Agomab Therapeutics NV — 2026-08-10","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-093390","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-093390-index.html"},{"accession_number":"0001104659-26-091992","form_type":"6-K","form_type_family":"current","doc_date":"2026-08-06","title":"6-K — Agomab Therapeutics NV — 2026-08-06","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-091992","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-091992-index.html"},{"accession_number":"0001104659-26-076819","form_type":"6-K","form_type_family":"current","doc_date":"2026-06-23","title":"6-K — Agomab Therapeutics NV — 2026-06-23","url_slug":"/sec/cik-0002020932/6-k/0001104659-26-076819","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020932/0001104659-26-076819-index.html"}],"related_endpoints":{"profile":"/sec/AGMB/profile","timeline":"/sec/AGMB/timeline","peers":"/sec/AGMB/peers","insider_pulse":"/sec/AGMB/insider-pulse","insider_summary":"/sec/AGMB/insider-summary","insider_transactions":"/sec/AGMB/insider-transactions","form144":"/sec/AGMB/form144","holdings_as_filer":"/sec/AGMB/holdings","financial_facts":"/sec/AGMB/financial-facts","derivatives":"/sec/AGMB/derivatives","officers":"/sec/AGMB/officers","insider_network":"/sec/AGMB/insider-network","risk_flags":"/sec/AGMB/risk-flags","filings":"/sec/AGMB/filings","cross_topic_dossier":"/api/v1/dossier?ticker=AGMB"}}